News
![](https://therapeutaix.com/wp-content/uploads/2024/06/IPF-AI.png)
AI Target Identification: A novel approach to drive drug R&D in IPF?
Within the realm of lung diseases, developing new drugs to treat Idiopathic Pulmonary Fibrosis (IPF) remains a formidable challenge. Characterized by progressive scarring of
![SMR meeting](https://therapeutaix.com/wp-content/uploads/2024/04/TherapeutAix-thumbnail-square-2.png)
Updates from SMR Meeting: ‘The Innovation Landscape’
Back in July 2022 the SMR (Society for Medicines Research) hosted a conference on ‘Innovative new pharma and biotech partnerships: How is the landscape transforming?’
![NASH TherapeutAix](https://therapeutaix.com/wp-content/uploads/2024/03/NASH_therapeutAix.png)
First drug approval in NASH
When we reviewed the R&D landscape in nonalcoholic steatohepatitis (NASH) in 2018, we highlighted 4 development programs that were in Phase 3 development and all
![SMR meeting](https://therapeutaix.com/wp-content/uploads/2024/03/TherapeutAix-thumbnail-square-1.png)
SMR meeting: The Innovation Landscape
On Tuesday 26 March Darcey Black, Translational Science Director at TherapeutAix, will be co-organising and co-sharing the SMR meeting taking place at Friends House, London.
![rare disease day 2024](https://therapeutaix.com/wp-content/uploads/2024/02/rare-disease-day-202467.png)
How rare diseases came to be defined: Rare Disease Day 2024
Today is Rare Disease Day, an international awareness day that takes place annually on 28th February (or 29th on leap years like this one) –
![](https://therapeutaix.com/wp-content/uploads/2024/01/TherapeutAix-parkrun.png)
Welcome 2024
With the New Year up and running, we all got together in Aachen for a Board Meeting. In addition to mapping out activities for 2024,
![TherapeutAix Roundup: 2023](https://therapeutaix.com/wp-content/uploads/2023/12/TherapeutAix-christmas-tile-square.png)
TherapeutAix Roundup: 2023
As 2023 comes to an end we wanted to take the time to reflect upon the year and share what we have been up to.